Pages that link to "Q30760301"
Jump to navigation
Jump to search
The following pages link to Anti-IL-17 phase II data for psoriasis: A review (Q30760301):
Displaying 20 items.
- Brodalumab for the Treatment of Psoriasis: A Review of Phase III Trials (Q26746100) (← links)
- Ixekizumab for the Treatment of Psoriasis: A Review of Phase III Trials (Q26766567) (← links)
- Treatment challenges in the management of moderate-to-severe plaque psoriasis - role of secukinumab (Q28069819) (← links)
- Immunity in arterial hypertension: associations or causalities? (Q28087302) (← links)
- The immunologic effects of estrogen on psoriasis: A comprehensive review (Q33640627) (← links)
- The flavonoid cyanidin blocks binding of the cytokine interleukin-17A to the IL-17RA subunit to alleviate inflammation in vivo. (Q33922498) (← links)
- Is hypertension an autoimmune disease? (Q34311505) (← links)
- T cells in vascular inflammatory diseases (Q34336323) (← links)
- Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2014 MauiDerm Meeting (Q34377347) (← links)
- Calcitonin Gene-Related Peptide-Exposed Endothelial Cells Bias Antigen Presentation to CD4+ T Cells toward a Th17 Response (Q36601088) (← links)
- The role of IL-17 in vitiligo: A review (Q36625953) (← links)
- Clinical efficacy and safety of anti-IL-17 agents for the treatment of patients with psoriasis (Q38521383) (← links)
- Therapeutic Antibody-Induced Vascular Toxicity Due to Off-Target Activation of Nitric Oxide in Cynomolgus Monkeys. (Q39966848) (← links)
- Moderate to severe psoriasis treatment challenges through the era of biological drugs (Q46452013) (← links)
- Response to Tetanus and Pneumococcal Vaccination Following Administration of Ixekizumab in Healthy Participants (Q47143243) (← links)
- The polymorphism rs763780 in the IL-17F gene is associated with response to biological drugs in patients with psoriasis. (Q50436409) (← links)
- Early relapse of psoriasis after stopping brodalumab: a retrospective cohort study in 77 patients. (Q50599204) (← links)
- Monoclonal Antibodies for the Management of Severe Asthma. (Q51687473) (← links)
- Do we need more psoriasis therapies? (Q55057104) (← links)
- Clinical potential of brodalumab in the management of psoriasis: the evidence to date. (Q55715868) (← links)